Next week, President Trump is scheduled to deliver a speech on drug pricing that will coincide with the release of a request for information (RFI) from the Department of Health and Human Services. This exclusive reporter briefing will feature a representative from the Administration, followed by a panel of industry leaders and stakeholders responding to new drug pricing guidance.